Alfred Novak

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX.

Part of Cardinal Health, Inc., Biosense, Inc. develops medical sensor technology. The company is based in Haifa, Israel. The Israeli company was founded by Amit Ben-Haim, Lewis C. Pell. Biosense was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on October 16, 1997.

ProRhythm, Inc. provides medical services. It developed HIFU (High Intensity Focused Ultrasound) for the treatment of atrial fibrillation (AF) a debilitating arrhythmia. The company was founded by David E. Acker in 1997 and is headquartered in Ronkonkoma, NY.

Sutura, Inc. develops invasive vascular suturing devices. The company also develops SuperStitch products which allow physicians to suture the arteriotomy or vascular tissue using fluoroscopic or ultrasonic. It was founded in 1996 and is headquartered in Fountain Valley, CA.

OrbusNeich Medical Technology Co. Ltd. is a Chinese medical device company that specializes in the treatment of vascular diseases. The private company is based in Hong Kong, Hong Kong, and has worldwide locations. The company's range of innovative devices includes balloons, stents, and specialty catheters that help simplify complex procedures for difficult lesions during coronary and peripheral procedures. OrbusNeich is committed to improving the long-term quality of life for patients through patient education. Bruce Wayne Johnson has been the CEO of the company since 2002.